Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2017

Open Access 01-12-2017 | Research article

Treating the invisible: Gaps and opportunities for enhanced TB control along the Thailand-Myanmar border

Authors: Naomi Tschirhart, Sein Sein Thi, Lei Lei Swe, Francois Nosten, Angel M. Foster

Published in: BMC Health Services Research | Issue 1/2017

Login to get access

Abstract

Background

In Thailand’s northwestern Tak province, contextual conditions along the border with Myanmar pose difficulties for TB control among migrant populations. Incomplete surveillance data, migrant patient mobility, and loss to follow-up make it difficult to estimate the TB burden and implement effective TB control measures. This multi-methods study examined tuberculosis, tuberculosis and human immunodeficiency virus co-infection, and multidrug-resistant tuberculosis treatment accessibility for migrants and refugees in Tak province, health system response, and public health surveillance.

Methods

In this study we conducted 13 interviews with key informants working in public health or TB treatment provision to elicit information on TB treatment availability and TB surveillance practices. In addition we organized 15 focus group discussions with refugee and migrant TB, TB/HIV, and MDR-TB patients and non-patients to discuss treatment access. We analyzed the data using thematic analysis and created treatment availability maps with Google maps.

Results

The study identified surveillance, treatment, and funding gaps. Migrant TB cases are underreported in the provincial statistics due to jurisdictional interpretations and resource barriers. Our results suggest that TB/HIV and MDR-TB treatment options are limited for migrants and a heavy reliance on donor funding may lead to potential funding gaps for migrant TB services. We identified several opportunities that positively contribute to TB control in Tak province: improved diagnostics, comprehensive care, and collaboration through data sharing, planning, and patient referrals. The various organizations providing TB treatment to migrant and refugee populations along the border and the Tak Provincial Public Health Office are highly collaborative which offers a strong foundation for future TB control initiatives.

Conclusions

Our findings suggest the need to enhance the surveillance system to include all migrant TB patients who seek treatment in Tak province and support efforts by stakeholders on both sides of the border to continue to share data and engage in collaborative planning on TB, TB/HIV, and MDR-TB treatment provision for migrant populations.
Literature
1.
Dara M, de Colombani P, Petrova-Benedict R, Centis R, Zellweger J-P, Sandgren A, et al. Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement. Eur Respir J. 2012;40(5):1081–90.CrossRefPubMedPubMedCentral
2.
Coker RJ, Atun RA, McKee M. Health-care system frailties and public health control of communicable disease on the European Union’s new eastern border. Lancet. 2004;363(9418):1389–92.CrossRefPubMed
3.
Noeske J, Foe J-LA, Kuaban C. Cameroon’s MDR-TB treatment programme jeopardised by cross-border migration. Eur Respir J. 2016;47(2):684–6.CrossRefPubMed
4.
Matteelli A, Lönnroth K, Mosca D, Getahun H, Centis R, D’Ambrosio L, et al. Cameroon’s multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migration. Eur Respir J. 2016;47(2):686–8.CrossRefPubMed
5.
6.
Coker RJ, Hunter BM, Rudge JW, Liverani M, Hanvoravongchai P. Emerging infectious diseases in Southeast Asia: Regional challenges to control. Lancet. 2011;377(9765):599–609.CrossRefPubMed
7.
8.
9.
10.
Hemhongsa P, Tasaneeyapan T, Swaddiwudhipong W, Danyuttapolchai J, Pisuttakoon K, Rienthong S, et al. TB, HIV-associated TB and multidrug-resistant TB on Thailand’s border with Myanmar, 2006–2007. Trop Med Int Heal. 2008;13(10):1288–96.CrossRef
11.
Kaji A, Thi SS, Smith T, Charunwatthana P, Nosten FH. Challenges in tackling tuberculosis on the Thai-Myanmar border: findings from a qualitative study with health professionals. BMC Health Serv Res. 2015;15:464.CrossRefPubMedPubMedCentral
12.
Iemrod K, Kavinum S. Strategies for Development of the Tuberculosis Control Program in Tak Province. Public Heal J Burapha Univ. 2015;10(1):1–14.
13.
Tschirhart N, Sein T, Nosten F, Foster AM. Migrant and refugee patient perspectives on travel and tuberculosis along the Thailand-Myanmar border: A Qualitative Study. PLoS One. 2016;11(8):e0160222.CrossRefPubMedPubMedCentral
14.
Tschirhart N, Nosten F, Foster AM. Access to free or low-cost tuberculosis treatment for migrants and refugees along the Thailand-Myanmar border in Tak province, Thailand. Int J Equity Health. 2016;15:100.CrossRefPubMedPubMedCentral
15.
Guba E, Lincoln Y. Competing paradigms in qualitative research. In: Denzin N, Lincoln Y, editors. Handbook of qualitative research. Thousand Oaks: Sage Publications; 1994. p. 105–17.
16.
17.
Narute S, Salgia K, Singhal P, Kalley V. Comparative study of gene Xpert MTB/RIF, smear microscopy and TB MGIT culture in diagnosis of tuberculosis in India. Eur Respir J. 2015;46(suppl 59):PA1533.
18.
Geleta DA, Megerssa YC, Gudeta AN, Akalu GT, Debele MT, Tulu KD. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility. BMC Microbiol. 2015;15:220.
19.
Churchyard GJ, Stevens WS, Mametja LD, McCarthy KM, Chihota V, Nicol MP, et al. Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF. Lancet Glob Heal. 2015; 3(8):e450–e457.
20.
21.
22.
Trauer JM, Achar J, Parpieva N, Khamraev A, Denholm JT, Falzon D, et al. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan. BMC Med. 2016;14(1):187.CrossRefPubMedPubMedCentral
23.
Guinto RLLR, Zuwasti Curran U, Suphanchaimat R, Pocock NS. Universal health coverage in “One ASEAN”: are migrants included? Glob Heal Action. 2015;8.
Metadata
Title
Treating the invisible: Gaps and opportunities for enhanced TB control along the Thailand-Myanmar border
Authors
Naomi Tschirhart
Sein Sein Thi
Lei Lei Swe
Francois Nosten
Angel M. Foster
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2017
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-016-1954-9

Other articles of this Issue 1/2017

BMC Health Services Research 1/2017 Go to the issue

Research article

Healthcare professionals’ views of the enhanced recovery after surgery programme: a qualitative investigation

Research article

Collaborative leadership and the implementation of community-based fall prevention initiatives: a multiple case study of public health practice within community groups

Research article

Descriptive study of interprofessional collaboration between physicians and osteopaths for the pediatric population in Quebec, Canada

Research article

Patient satisfaction with doctor-patient interactions: a mixed methods study among diabetes mellitus patients in Pakistan

Research article

Typology of birth centres in the Netherlands using the Rainbow model of integrated care: results of the Dutch Birth Centre Study

Research article

Health-care utilization of patients with chronic back pain before and after rehabilitation